The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Molecular Biology of Burkitt’s Lymphoma
Abstract
The diagnostic category of Burkitt’s lymphoma encompasses a closely related group of aggressive B-cell tumors that includes sporadic, endemic, and human immunodeficiency virus–associated subtypes. All subtypes are characterized by chromosomal rearrangements involving the c-myc proto-oncogene that lead to its inappropriate expression. This review focuses on the roles of c-myc dysregulation and Epstein-Barr virus infection in Burkitt’s lymphoma. Although the normal function of c-Myc remains enigmatic, recent data indicate that it has a central role in several fundamental aspects of cellular biology, including proliferation, differentiation, metabolism, apoptosis, and telomere maintenance. We discuss new insights into the molecular mechanisms of these c-Myc activities and their potential relevance to the pathogenesis of Burkitt’s lymphoma and speculate on the role of Epstein-Barr virus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature · doi:10.1038/35000501 · Cited by 9,925
Harris, N., Jaffe, E., Stein, H., Banks, P., Chan, J., Cleary, M., Delsol, G., De Wolf- Peeters, C., Falini, B., & Gatter, K. (1994) · Blood · doi:10.1182/blood.v84.5.1361.1361 · Cited by 6,327
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Tissue microarrays for high-throughput molecular profiling of tumor specimens
Kononen, J., Bubendorf, L., Kallionimeni, A., Bärlund, M., Schraml, P., Leighton, S., Torhorst, J., Mihatsch, M. J., Sauter, G., & Kallionimeni, O.-P. (1998) · Nature Medicine · doi:10.1038/nm0798-844 · Cited by 4,099
The Non-Hodgkin's Lymphoma Pathologic Classification Project (1982) · Cancer · doi:10.1002/1097-0142(19820515)49:10<2112::aid-cncr2820491024>3.0.co;2-2 · Cited by 3,059
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804
VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA
Epstein, M. A., Achong, B. G., & Barr, Y. M. (1964) · The Lancet · doi:10.1016/s0140-6736(64)91524-7 · Cited by 2,778
Dalla-Favera, R., Bregni, M., Erikson, J., Patterson, D., Gallo, R. C., & Croce, C. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.24.7824 · Cited by 1,773
c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism
Dang, C. V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.1 · Cited by 1,715
Taub, R., Kirsch, I., Morton, C., Lenoir, G., Swan, D., Tronick, S., Aaronson, S., & Leder, P. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.24.7837 · Cited by 1,422
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
Zindy, F., Eischen, C. M., Randle, D. H., Kamijo, T., Cleveland, J. L., Sherr, C. J., & Roussel, M. F. (1998) · Genes & Development · doi:10.1101/gad.12.15.2424 · Cited by 1,245
A complex containing N-CoR, mSln3 and histone deacetylase mediates transcriptional repression
Heinzel, T., Lavinsky, R. M., Mullen, T.-M., Söderström, M., Laherty, C. D., Torchia, J., Yang, W.-M., Brard, G., Ngo, S. D., Davie, J. R., et al. (1997) · Nature · doi:10.1038/387043a0 · Cited by 1,214
Cellular Oncogenes and Multistep Carcinogenesis
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Science · doi:10.1126/science.6356358 · Cited by 1,127
c-Myc transactivation of LDH-A : Implications for tumor metabolism and growth
Shim, H., Dolde, C., Lewis, B. C., Wu, C.-S., Dang, G., Jungmann, R. A., Dalla-Favera, R., & Dang, C. V. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6658 · Cited by 1,092
Grant, P. A., Duggan, L., Côté, J., Roberts, S. M., Brownell, J. E., Candau, R., Ohba, R., Owen-Hughes, T., Allis, C. D., Winston, F., et al. (1997) · Genes & Development · doi:10.1101/gad.11.13.1640 · Cited by 1,085
Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF
Jacobs, J. J. L., Scheijen, B., Voncken, J.-W., Kieboom, K., Berns, A., & van Lohuizen, M. (1999) · Genes & Development · doi:10.1101/gad.13.20.2678 · Cited by 1,065
Apoptotic cell death induced by c-myc is inhibited by bcl-2
Bissonnette, R. P., Echeverri, F., Mahboubi, A., & Green, D. R. (1992) · Nature · doi:10.1038/359552a0 · Cited by 957
The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation
Raab-Traub, N., & Flynn, K. (1986) · Cell · doi:10.1016/0092-8674(86)90803-2 · Cited by 912
Direct activation of TERT transcription by c-MYC
Wu, K.-J., Grandori, C., Amacker, M., Simon-Vermot, N., Polack, A., Lingner, J., & Dalla-Favera, R. (1999) · Nature Genetics · doi:10.1038/6010 · Cited by 893
Gaidano, G., Ballerini, P., Gong, J. Z., Inghirami, G., Neri, A., Newcomb, E. W., Magrath, I. T., Knowles, D. M., & Dalla-Favera, R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5413 · Cited by 885
Reversible Tumorigenesis by MYC in Hematopoietic Lineages
Felsher, D. W., & Bishop, J. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80367-6 · Cited by 881
Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression
Alland, L., Muhle, R., Hou, H., Potes, J., Chin, L., Schreiber-Agus, N., & DePinho, R. A. (1997) · Nature · doi:10.1038/387049a0 · Cited by 844
Coller, H. A., Grandori, C., Tamayo, P., Colbert, T., Lander, E. S., Eisenman, R. N., & Golub, T. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3260 · Cited by 823
Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis
Eischen, C. M., Weber, J. D., Roussel, M. F., Sherr, C. J., & Cleveland, J. L. (1999) · Genes & Development · doi:10.1101/gad.13.20.2658 · Cited by 819
Bentley, D. L., & Groudine, M. (1986) · Nature · doi:10.1038/321702a0 · Cited by 811
Marcu, K. B., Bossone, S. A., & Patel, A. J. (1992) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.61.070192.004113 · Cited by 802
The ornithine decarboxylase gene is a transcriptional target of c-Myc.
Bello-Fernandez, C., Packham, G., & Cleveland, J. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.16.7804 · Cited by 777
Cooperative interaction between c-myc and bcl-2 proto-oncogenes
Fanidi, A., Harrington, E. A., & Evan, G. I. (1992) · Nature · doi:10.1038/359554a0 · Cited by 759
Mediation of c-Myc-Induced Apoptosis by p53
Hermeking, H., & Eick, D. (1994) · Science · doi:10.1126/science.8091232 · Cited by 739
Druker, B. J., & Lydon, N. B. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9083 · Cited by 707
Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity
Ayer, D. E., Kretzner, L., & Eisenman, R. N. (1993) · Cell · doi:10.1016/0092-8674(93)90661-9 · Cited by 703
The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins
McMahon, S. B., Van Buskirk, H. A., Dugan, K. A., Copeland, T. D., & Cole, M. D. (1998) · Cell · doi:10.1016/s0092-8674(00)81479-8 · Cited by 693
Cdc25 cell-cycle phosphatase as a target of c-myc
Galaktionov, K., Chen, X., & Beach, D. (1996) · Nature · doi:10.1038/382511a0 · Cited by 690
Wang, J., Xie, L. Y., Allan, S., Beach, D., & Hannon, G. J. (1998) · Genes & Development · doi:10.1101/gad.12.12.1769 · Cited by 653
Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development
Gao, Y., Ferguson, D. O., Xie, W., Manis, J. P., Sekiguchi, J., Frank, K. M., Chaudhuri, J., Horner, J., DePinho, R. A., & Alt, F. W. (2000) · Nature · doi:10.1038/35009138 · Cited by 580
Oncogenic activity of the c-Myc protein requires dimerization with Max
Amati, B., Brooks, M. W., Levy, N., Littlewood, T. D., Evan, G. I., & Land, H. (1993) · Cell · doi:10.1016/0092-8674(93)90663-b · Cited by 560
Harris, N. L. (1995) · Current Diagnostic Pathology · doi:10.1016/s0968-6053(00)80051-4 · Cited by 527
Dalla-Favera, R., Martinotti, S., Gallo, R. C., Erikson, J., & Croce, C. M. (1983) · Science · doi:10.1126/science.6401867 · Cited by 504
KNOWLES, D. M., CHAMULAK, G. A., SUBAR, M., BURKE, J. S., DUGAN, M., WERNZ, J., SLYWOTZKY, C., PELICCI, P., DALLA-FAVERA, R., & RAPHAEL, B. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-5-744 · Cited by 501
The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc
McMahon, S. B., Wood, M. A., & Cole, M. D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.2.556-562.2000 · Cited by 494
Gregory, M. A., & Hann, S. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.7.2423-2435.2000 · Cited by 469
The Pathogenesis of Burkitt's Lymphoma
(1990) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60470-4 · Cited by 466
Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max
Amati, B., Dalton, S., Brooks, M. W., Littlewood, T. D., Evan, G. I., & Land, H. (1992) · Nature · doi:10.1038/359423a0 · Cited by 460
INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53
Schmitt, C. A., McCurrach, M. E., de Stanchina, E., Wallace-Brodeur, R. R., & Lowe, S. W. (1999) · Genes & Development · doi:10.1101/gad.13.20.2670 · Cited by 458
Myc and Max proteins possess distinct transcriptional activities
Kretzner, L., Blackwood, E. M., & Eisenman, R. N. (1992) · Nature · doi:10.1038/359426a0 · Cited by 453
Salghetti, S. E. (1999) · The EMBO Journal · doi:10.1093/emboj/18.3.717 · Cited by 443
The c-myc oncogene perturbs B lymphocyte development in Eμ-myc transgenic mice
Langdon, W. Y., Harris, A. W., Cory, S., & Adams, J. M. (1986) · Cell · doi:10.1016/0092-8674(86)90361-2 · Cited by 433
Transient excess of MYC activity can elicit genomic instability and tumorigenesis
Felsher, D. W., & Bishop, J. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3940 · Cited by 419
Function of the c-Myc Oncogenic Transcription Factor
Dang, C. V., Resar, L. M. S., Emison, E., Kim, S., Li, Q., Prescott, J. E., Wonsey, D., & Zeller, K. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4686 · Cited by 379
Binding of myc proteins to canonical and noncanonical DNA sequences.
Blackwell, T. K., Huang, J., Ma, A., Kretzner, L., Alt, F. W., Eisenman, R. N., & Weintraub, H. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.9.5216 · Cited by 376
In Vivo Eradication of Human BCR/ABL-Positive Leukemia Cells With an ABL Kinase Inhibitor
le Coutre, P., Mologni, L., Cleris, L., Marchesi, E., Buchdunger, E., Giardini, R., Formelli, F., & Gambacorti-Passerini, C. (1999) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/91.2.163 · Cited by 374
Schreiber-Agus, N., Chin, L., Chen, K., Torres, R., Rao, G., Guida, P., Skoultchi, A. I., & DePinho, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90356-9 · Cited by 364
Pelicci, P. G., Knowles, D. M., Magrath, I., & Dalla-Favera, R. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.9.2984 · Cited by 354
Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ
Thompson, T. C., Southgate, J., Kitchener, G., & Land, H. (1989) · Cell · doi:10.1016/0092-8674(89)90625-9 · Cited by 352
Shou, Y., Martelli, M. L., Gabrea, A., Qi, Y., Brents, L. A., Roschke, A., Dewald, G., Kirsch, I. R., Bergsagel, P. L., & Kuehl, W. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.228 · Cited by 347
Hypermethylation of the DAP-Kinase CpG Island Is a Common Alteration in B-Cell Malignancies
Katzenellenbogen, R. A., Baylin, S. B., & Herman, J. G. (1999) · Blood · doi:10.1182/blood.v93.12.4347 · Cited by 345
Cytogenetic findings in 200 patients with multiple myeloma
Sawyer, J. R., Waldron, J. A., Jagannath, S., & Barlogie, B. (1995) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(94)00284-i · Cited by 343
Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice.
Wilson, J. B., Bell, J. L., & Levine, A. J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00674.x · Cited by 334
Mateyak, M. K., Obaya, A. J., & Sedivy, J. M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.4672 · Cited by 331
Coordinated Regulation of Iron-Controlling Genes, H-Ferritin and IRP2 , by c-MYC
Wu, K.-J., Polack, A., & Dalla-Favera, R. (1999) · Science · doi:10.1126/science.283.5402.676 · Cited by 326
ar-Rushdi, A., Nishikura, K., Erikson, J., Watt, R., Rovera, G., & Croce, C. M. (1983) · Science · doi:10.1126/science.6414084 · Cited by 324
Li, L. H., Nerlov, C., Prendergast, G., MacGregor, D., & Ziff, E. B. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06724.x · Cited by 311
The Role of Somatic Hypermutation in the Generation of Antibody Diversity
French, D. L., Laskov, R., & Scharff, M. D. (1989) · Science · doi:10.1126/science.2658060 · Cited by 301
Bahram, F., von der Lehr, N., Cetinkaya, C., & Larsson, L.-G. (2000) · Blood · doi:10.1182/blood.v95.6.2104 · Cited by 286
Max: functional domains and interaction with c-Myc.
Kato, G. J., Lee, W. M., Chen, L. L., & Dang, C. V. (1992) · Genes & Development · doi:10.1101/gad.6.1.81 · Cited by 282
Wick, M., Zubov, D., & Hagen, G. (1999) · Gene · doi:10.1016/s0378-1119(99)00108-0 · Cited by 280
Corn, P. G., Kuerbitz, S. J., van Noesel, M. M., Esteller, M., Compitello, N., Baylin, S. B., & Herman, J. G. (1999) · PubMed · Cited by 280
Hamilton-Dutoit, S. J., Pallesen, G., Franzmann, M. B., Karkov, J., Black, F. T., Skinhøj, P., & Pedersen, C. (1991) · PubMed · Cited by 276
c-Myc target gene specificity is determined by a post-DNAbinding mechanism
Boyd, K. E., Wells, J., Gutman, J., Bartley, S. M., & Farnham, P. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13887 · Cited by 276
V(D)J Recombinase Activity in a Subset of Germinal Center B Lymphocytes
Han, S., Dillon, S. R., Zheng, B., Shimoda, M., Schlissel, M. S., & Kelsoe, G. (1997) · Science · doi:10.1126/science.278.5336.301 · Cited by 274
Cohen, O., Inbal, B., Kissil, J. L., Raveh, T., Berissi, H., Spivak-Kroizaman, T., Feinstein, E., & Kimchi, A. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.1.141 · Cited by 274
Oncogenic Role of Epstein-Barr Virus-Encoded RNAs in Burkitt’s Lymphoma Cell Line Akata
Komano, J. A., Maruo, S., Kurozumi, K., Oda, T., & Takada, K. (1999) · Journal of Virology · doi:10.1128/jvi.73.12.9827-9831.1999 · Cited by 268
Activation of a translocated human c-myc gene by an enhancer in the immunoglobulin heavy-chain locus
Hayday, A. C., Gillies, S. D., Saito, H., Wood, C., Wiman, K., Hayward, W. S., & Tonegawa, S. (1984) · Nature · doi:10.1038/307334a0 · Cited by 266
Rosenwald, I. B., Rhoads, D. B., Callanan, L. D., Isselbacher, K. J., & Schmidt, E. V. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.6175 · Cited by 255
Jones, R. M., Branda, J., Johnston, K. A., Polymenis, M., Gadd, M., Rustgi, A., Callanan, L., & Schmidt, E. V. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4754 · Cited by 237
Neri, A., Barriga, F., Knowles, D. M., Magrath, I. T., & Dalla-Favera, R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.8.2748 · Cited by 235
Mutations in the First Exon Are Associated with Altered Transcription of c- myc in Burkitt Lymphoma
Cesarman, E., Dalla-Favera, R., Bentley, D., & Groudine, M. (1987) · Science · doi:10.1126/science.3685977 · Cited by 221
Reexpression of RAG-1 and RAG-2 Genes in Activated Mature Mouse B cells
Hikida, M., Mori, M., Takai, T., Tomochika, K.-I., Hamatani, K., & Ohmori, H. (1996) · Science · doi:10.1126/science.274.5295.2092 · Cited by 210
Grandori, C., Mac, J., Siëbelt, F., Ayer, D. E., & Eisenman, R. N. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00808.x · Cited by 208
Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia.
Capello, D., Vitolo, U., Pasqualucci, L., Quattrone, S., Migliaretti, G., Fassone, L., Ariatti, C., Vivenza, D., Gloghini, A., Pastore, C., et al. (2000) · PubMed · doi:10.1182/blood.v95.2.651 · Cited by 198
Regulation of cell cycle duration by c-myc levels.
Karn, J., Watson, J. V., Lowe, A. D., Green, S. M., & Vedeckis, W. V. (1989) · PubMed · Cited by 192
Chromatin Remodeling and Leukemia: New Therapeutic Paradigms
Redner, R. L., Wang, J., & Liu, J. M. (1999) · Blood · doi:10.1182/blood.v94.2.417 · Cited by 189
Prochownik, E. V., Kukowska, J., & Rodgers, C. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.9.3683 · Cited by 189
Macpherson, N., Lesack, D., Klasa, R., Horsman, D., Connors, J. M., Barnett, M., & Gascoyne, R. D. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.5.1558 · Cited by 179
Haluska, F. G., Finver, S., Tsujimoto, Y., & Croce, C. M. (1986) · Nature · doi:10.1038/324158a0 · Cited by 178
New Myc-interacting proteins: a second Myc network emerges
Sakamuro, D., & Prendergast, G. C. (1999) · Oncogene · doi:10.1038/sj.onc.1202725 · Cited by 177
Miltenberger, R. J., Sukow, K. A., & Farnham, P. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2527 · Cited by 172
c-myc null cells misregulate cad and gadd45 but not other proposed c-Myc targets
Bush, A., Mateyak, M., Dugan, K., Obaya, A., Adachi, S., Sedivy, J., & Cole, M. (1998) · Genes & Development · doi:10.1101/gad.12.24.3797 · Cited by 172
Myc versus USF: Discrimination at the cad Gene Is Determined by Core Promoter Elements
Boyd, K. E., & Farnham, P. J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.5.2529 · Cited by 167
Müller, D., Bouchard, C., Rudolph, B., Steiner, P., Stuckmann, I., Saffrich, R., Ansorge, W., Huttner, W., & Eilers, M. (1997) · Oncogene · doi:10.1038/sj.onc.1201440 · Cited by 167
Epstein-Barr Virus (EBV) in Endemic Burkitt's Lymphoma: Molecular Analysis of Primary Tumor Tissue
Tao, Q., Robertson, K. D., Manns, A., Hildesheim, A., & Ambinder, R. F. (1998) · Blood · doi:10.1182/blood.v91.4.1373 · Cited by 166
Transcriptional control of the endogenous MYC protooncogene by antisense RNA.
Yokoyama, K., & Imamoto, F. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7363 · Cited by 150
Opposite regulation of gene transcription and cell proliferation by c-Myc and Max.
Gu, W. J., Cechova, K., Tassi, V., & Dalla‐Favera, R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.7.2935 · Cited by 144
Tra1p Is a Component of the Yeast Ada·Spt Transcriptional Regulatory Complexes
Saleh, A., Schieltz, D. M., Ting, N. S. Y., McMahon, S. B., Litchfield, D. W., Yates, J. R., Lees‐Miller, S. P., Cole, M. D., & Brandl, C. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26559 · Cited by 136
Levy-Strumpf, N., & Kimchi, A. (1998) · Oncogene · doi:10.1038/sj.onc.1202588 · Cited by 136
Cohen, O. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.999.141 · Cited by 135
Akasaka, T., Akasaka, H., Ueda, C., Yonetani, N., Maesako, Y., Shimizu, A., Yamabe, H., Fukuhara, S., Uchiyama, T., & Ohno, H. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.3.510 · Cited by 134
Flinn, E. M., Busch, C. M. C., & Wright, A. P. H. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.10.5961 · Cited by 131
Myc-mediated transformation: the repression connection
Claassen, G. F., & Hann, S. (1999) · Oncogene · doi:10.1038/sj.onc.1202747 · Cited by 128
Epstein-Barr Virus Regulates c-MYC, Apoptosis, and Tumorigenicity in Burkitt Lymphoma
Ruf, I. K., Rhyne, P., Yang, H. J., Borza, C. M., Hutt‐Fletcher, L. M., Cleveland, J. L., & Sample, J. T. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1651 · Cited by 127
Joos, S., Falk, M. H., Lichter, P., Haluska, F. G., Henglein, B., Lenoir, G., & Bornkamm, G. W. (1992) · Human Molecular Genetics · doi:10.1093/hmg/1.8.625 · Cited by 105
Chapman, C., Zhou, J., Gregory, C. D., Rickinson, A. B., & Stevenson, F. K. (1996) · Blood · doi:10.1182/blood.v88.9.3562.bloodjournal8893562 · Cited by 105
Cell growth inhibition by the Mad/Max complex through recruitment of histone deacetylase activity
Sommer, A., Hilfenhaus, S., Menkel, A. R., Kremmer, E., Seiser, C., Loidl, P., & Lüscher, B. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00183-7 · Cited by 102
A Point Mutation in the c- myc Locus of a Burkitt Lymphoma Abolishes Binding of a Nuclear Protein
Zajac‐Kaye, M., Gelmann, E. P., & Levens, D. (1988) · Science · doi:10.1126/science.2454510 · Cited by 101
Lymphomas associated with HIV infection.
Diebold, J., Raphaël, M., Prevot, S., & Audouin, J. (1997) · PubMed · Cited by 87
Role of histone deacetylases in acute leukemia
Fenrick, R., & Hiebert, S. W. (1998) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(1998)72:30/31+<194::aid-jcb24>3.0.co;2-h · Cited by 73
Two MAD tails: what the recent knockouts of Mad1 and Mxi1 tell us about the MYC/MAX/MAD network
Foley, K. P., & Eisenman, R. N. (1999) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(99)00012-8 · Cited by 72
Schuldiner, O., Eden, A., Ben‐Yosef, T., Yanuka, O., Simchen, G., & Benvenisty, N. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7143 · Cited by 70
A novel function for Myc: inhibition of C/EBP-dependent gene activation.
Mink, S., Mutschler, B., Weiskirchen, R., Bister, K., & Klempnauer, K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6635 · Cited by 60
Deregulation of the proto-oncogene c-myc through t(8;22) translocation in Burkitt's lymphoma
Gerbitz, A., Mautner, J., Geltinger, C., Hörtnagel, K., Christoph, B., Asenbauer, H., Klobeck, G., Polack, A., & Bornkamm, G. W. (1999) · Oncogene · doi:10.1038/sj.onc.1202468 · Cited by 60
Haluska, F. G., Tsujimoto, Y., & Croce, C. M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.19.6835 · Cited by 53
Sin3 corepressor function in Myc-induced transcription and transformation.
Harper, S. E., Qiu, Y., & Sharp, P. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8536 · Cited by 49
Mnt: A Novel Max-interacting Protein and Myc Antagonist
Hurlin, P. J., Quéva, C., & Eisenman, R. N. (1997) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-60801-8_11 · Cited by 46
Mai, S., & Jalava, A. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.12.2264 · Cited by 46
Haupt, Y., Harris, A. W., & Adams, J. M. (1992) · PubMed · Cited by 42
Zajac‐Kaye, M., & Levens, D. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39597-3 · Cited by 41
Subtracted, Unique-Sequence, In Situ Hybridization
Davison, J. M., Morgan, T. W., Hsi, B., Xiao, S., & Fletcher, J. A. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65727-6 · Cited by 36
Palomo, C., Zou, X., Nicholson, I., Bützler, C., & Brüggemann, M. (1999) · PubMed · Cited by 30
Cellular Targets for Activation by c-Myc Include the DNA Metabolism Enzyme Thymidine Kinase
Pusch, O., Soucek, T., Hengstschläger-Ottnad, E., BERNASCHEK, G., & Hengstschläger, M. (1997) · DNA and Cell Biology · doi:10.1089/dna.1997.16.737 · Cited by 30
Mutations of the p53 Gene in B-cell Lymphoma
Ichikawa, A., Hotta, T., & Saito, H. (1993) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199309054727 · Cited by 15
17p Anomalies in Lymphoid Malignancies: Diagnostic and Prognostic Implications
Schoch, C., Rieder, H., Stollmann-Gibbels, B., Freund, M., Tischler, H., Silling-Engelhardt, G., & Fonatsch, C. (1995) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199509056832 · Cited by 15
Dissection of c-myc domains involved in S phase induction of NIH3T3 fibroblasts.
Goruppi, S., Gustincich, S., Brancolini, C., Lee, W. M. F., & Schneider, C. (1994) · PubMed · Cited by 10
Cited by
Fu, L., Pelicano, H., Liu, J., Huang, P., & Lee, C. C. (2002) · Cell · doi:10.1016/s0092-8674(02)00961-3 · Cited by 1,270
A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling
Hummel, M., Bentink, S., Berger, H., Klapper, W., Wessendorf, S., Barth, T. F. E., Bernd, H.-W., Cogliatti, S. B., Dierlamm, J., Feller, A. C., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055351 · Cited by 1,006
Molecular Diagnosis of Burkitt's Lymphoma
Dave, S. S., Fu, K., Wright, G. W., Lam, L. T., Kluin, P., Boerma, E.-J., Greiner, T. C., Weisenburger, D. D., Rosenwald, A., Ott, G., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055759 · Cited by 897
Adult Burkitt leukemia and lymphoma
Blum, K. A., Lozanski, G., & Byrd, J. C. (2004) · Blood · doi:10.1182/blood-2004-02-0405 · Cited by 579
SPECTRUM OF EPSTEIN-BARR VIRUS–ASSOCIATED DISEASES
Kutok, J. L., & Wang, F. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100209 · Cited by 493
Metadata
- Authors
- Hecht, J. L., & Aster, J. C.
- Venue
- Journal of Clinical Oncology
- Published
- 2000-11-01
- Volume
- 18
- Issue
- 21
- Pages
- 3707-3721
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1947622855
- Cited by
- 439
- References
- 122
- FWCI
- 8.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.